EnsoData Raises $9M To Diagnose Health Conditions With AI
Summary
EnsoData, a Madison, Wisconsin-based startup that is using artificial intelligence to analyze the human body to diagnose health conditions, today announced the close of $9 million in funding. The company’s trio of co-founders met nearly a decade ago while attending the University of Wisconsin where CEO Chris Fernandez told me they “fell in love with the confluence of AI, massive data sets and working with bright clinicians to support problems in health care.” Over the years, they have developed technology they claim simplifies the process of analyzing the human body to accurately diagnose health conditions. We’re using AI to further humanize health care, rather than taking it away with technology.” Mark Gorenberg, managing director at Zetta Venture Partners, described EnsoData as “the early mover to the market.” “We spend a third of our lives asleep, yet the majority of disorders that disrupt it go undetected–a problem of this scale translates to an enormous opportunity for the company,” he said. We think they have the opportunity to set the gold standard in sleep disorder diagnosis.” Scott Button, managing director of Venture Investors, said he first met EnsoData’s co-founders when they were students at the University of Wisconsin. “Since that moment, I have been impressed with their unbridled passion, infectious enthusiasm, and desire to improve patient care using medical waveform artificial intelligence,” he said.